ASX:OILHealth Care Equipment & ServicesHealth Care Equipment
Optiscan Imaging Ltd
$0.145
Day Range
$0.145 – $0.150
52 Week Range
$0.078 – $0.160
Volume
0.00
Avg Volume (10D)
193.68K
Market Cap
$151.41M
Price Chart
Market Statistics
Open$0.145
Previous Close$0.145
Day High$0.150
Day Low$0.145
52 Week High$0.160
52 Week Low$0.078
Valuation
Market Cap151.41M
Shares Outstanding1.04B
Price to Book6.87
Trading Activity
Volume0.00
Value Traded0.00
Bid$0.145 × 37,400
Ask$0.155 × 56,777
Performance
1 Day-3.33%
5 Day-9.38%
13 Week31.82%
52 Week39.04%
YTD45.00%
Technical Indicators
RSI (14)49.33
50-Day SMA$0.136
200-Day SMA$0.111
Latest News
Biotechnology
Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule
Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical validation and potential FDA submissions.
Biotechnology
Optiscan Imaging Launches First Clinical Device into US Veterinary Market
Optiscan debuts InSpecta as its first US commercial clinical imaging device after FDA CVM submission, unlocking US sales in a $15.9B market.
Biotechnology
Optiscan Submits FDA Dossier for Inspecta Imaging Device Targeting Lucrative US Veterinary Market
Optiscan submits FDA dossier for InSpecta veterinary imaging, unlocking US$11.9B market with real-time, non-invasive imaging for pets.
Biotechnology
Optiscan Imaging Launches Head and Neck Cancer Study Using Invue and InForm Digital Pathology Tools
Optiscan Imaging (ASX: OIL) has partnered with Australian Clinical Labs to launch the nation’s first-in-human head and neck cancer imaging study utilising the InVue and InForm digital pathology devices.